These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 33826547

  • 1. Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas.
    Mete O, Pakbaz S, Lerario AM, Giordano TJ, Asa SL.
    Am J Surg Pathol; 2021 Sep 01; 45(9):1264-1273. PubMed ID: 33826547
    [Abstract] [Full Text] [Related]

  • 2. The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma.
    Wang Y, Liu B, Li F, Zhang Y, Gao X, Wang Y, Zhou H.
    Front Endocrinol (Lausanne); 2023 Sep 01; 14():1274239. PubMed ID: 37867526
    [Abstract] [Full Text] [Related]

  • 3. Genetic and epigenetic differences of benign and malignant pheochromocytomas and paragangliomas (PPGLs).
    Khatami F, Mohammadamoli M, Tavangar SM.
    Endocr Regul; 2018 Jan 01; 52(1):41-54. PubMed ID: 29453919
    [Abstract] [Full Text] [Related]

  • 4. Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma.
    van Berkel A, Rao JU, Kusters B, Demir T, Visser E, Mensenkamp AR, van der Laak JA, Oosterwijk E, Lenders JW, Sweep FC, Wevers RA, Hermus AR, Langenhuijsen JF, Kunst DP, Pacak K, Gotthardt M, Timmers HJ.
    J Nucl Med; 2014 Aug 01; 55(8):1253-9. PubMed ID: 24925884
    [Abstract] [Full Text] [Related]

  • 5. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A, Rao JU, Lenders JW, Pellegata NS, Kusters B, Piscaer I, Hermus AR, Plantinga TS, Langenhuijsen JF, Vriens D, Janssen MJ, Gotthardt M, Timmers HJ.
    J Nucl Med; 2015 Jun 01; 56(6):839-46. PubMed ID: 25883126
    [Abstract] [Full Text] [Related]

  • 6. The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma.
    Peng S, Zhang J, Tan X, Huang Y, Xu J, Silk N, Zhang D, Liu Q, Jiang J.
    Front Endocrinol (Lausanne); 2020 Jun 01; 11():586857. PubMed ID: 33329393
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma.
    Jiang J, Zhang J, Pang Y, Bechmann N, Li M, Monteagudo M, Calsina B, Gimenez-Roqueplo AP, Nölting S, Beuschlein F, Fassnacht M, Deutschbein T, Timmers HJLM, Åkerström T, Crona J, Quinkler M, Fliedner SMJ, Liu Y, Guo J, Li X, Guo W, Hou Y, Wang C, Zhang L, Xiao Q, Liu L, Gao X, Burnichon N, Robledo M, Eisenhofer G.
    J Clin Endocrinol Metab; 2020 Oct 01; 105(10):. PubMed ID: 32750708
    [Abstract] [Full Text] [Related]

  • 9. Metabolic Subtyping of Pheochromocytoma and Paraganglioma by 18F-FDG Pharmacokinetics Using Dynamic PET/CT Scanning.
    van Berkel A, Vriens D, Visser EP, Janssen MJR, Gotthardt M, Hermus ARMM, Geus-Oei LF, Timmers HJLM.
    J Nucl Med; 2019 Jun 01; 60(6):745-751. PubMed ID: 30413658
    [Abstract] [Full Text] [Related]

  • 10. New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.
    Taïeb D, Pacak K.
    Trends Endocrinol Metab; 2017 Nov 01; 28(11):807-817. PubMed ID: 28867159
    [Abstract] [Full Text] [Related]

  • 11. GIPC2 is an endocrine-specific tumor suppressor gene for both sporadic and hereditary tumors of RET- and SDHB-, but not VHL-associated clusters of pheochromocytoma/paraganglioma.
    Dong Y, Huang Y, Fan C, Wang L, Zhang R, Li W, Guo Z, Wang D, Zheng Z.
    Cell Death Dis; 2021 May 04; 12(5):444. PubMed ID: 33947839
    [Abstract] [Full Text] [Related]

  • 12. Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.
    Fischer A, Kloos S, Maccio U, Friemel J, Remde H, Fassnacht M, Pamporaki C, Eisenhofer G, Timmers HJLM, Robledo M, Fliedner SMJ, Wang K, Maurer J, Reul A, Zitzmann K, Bechmann N, Žygienė G, Richter S, Hantel C, Vetter D, Lehmann K, Mohr H, Pellegata NS, Ullrich M, Pietzsch J, Ziegler CG, Bornstein SR, Kroiss M, Reincke M, Pacak K, Grossman AB, Beuschlein F, Nölting S.
    J Clin Endocrinol Metab; 2023 Sep 18; 108(10):2676-2685. PubMed ID: 36946182
    [Abstract] [Full Text] [Related]

  • 13. Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paraganglioma.
    Murakami M, Sun N, Greunke C, Feuchtinger A, Kircher S, Deutschbein T, Papathomas T, Bechmann N, William Wallace P, Peitzsch M, Korpershoek E, Friemel J, Gimenez-Roqueplo AP, Robledo M, J L M Timmers H, Canu L, Weber A, R de Krijger R, Fassnacht M, Knösel T, Kirchner T, Reincke M, Karl Walch A, Kroiss M, Beuschlein F.
    Eur J Endocrinol; 2021 Jun 05; 185(1):179-191. PubMed ID: 33983135
    [Abstract] [Full Text] [Related]

  • 14. Morphologic Clues to Succinate Dehydrogenase (SDH) Deficiency in Pheochromocytomas and Paragangliomas.
    Turchini J, Gill AJ.
    Am J Surg Pathol; 2020 Mar 05; 44(3):422-424. PubMed ID: 31789631
    [No Abstract] [Full Text] [Related]

  • 15. Diagnostic role of inhibin α-subunit and inhibin/activin β-subunit in adrenal cortical and medullary tumors in Egyptian patients.
    Elmoneim HM, Samaka RM, Ali H.
    Appl Immunohistochem Mol Morphol; 2012 Oct 05; 20(5):462-9. PubMed ID: 22417854
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
    Bernardo-Castiñeira C, Sáenz-de-Santa-María I, Valdés N, Astudillo A, Balbín M, Pitiot AS, Jiménez-Fonseca P, Scola B, Tena I, Molina-Garrido MJ, Sevilla MA, Beristein E, Forga L, Villabona C, Oriola J, Halperin I, Suarez C, Chiara MD.
    Head Neck; 2019 Jan 05; 41(1):79-91. PubMed ID: 30549360
    [Abstract] [Full Text] [Related]

  • 17. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
    Eisenhofer G, Deutschbein T, Constantinescu G, Langton K, Pamporaki C, Calsina B, Monteagudo M, Peitzsch M, Fliedner S, Timmers HJLM, Bechmann N, Fankhauser M, Nölting S, Beuschlein F, Stell A, Fassnacht M, Prejbisz A, Lenders JWM, Robledo M.
    Clin Chem Lab Med; 2020 Oct 01; 59(2):353-363. PubMed ID: 33001846
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.